当前位置: 首页 > 期刊 > 《中国现代医生》 > 202028
编号:13799224
盐酸利托君与硫酸镁治疗先兆早产患者的效果对照(1)
http://www.100md.com 2020年10月5日 《中国现代医生》 202028
     [摘要] 目的 探讨盐酸利托君与硫酸镁治疗先兆早产患者的效果。 方法 选取2018年1~12月我院产科接收的先兆早产孕妇120例作为研究对象,根据随机数字表法进行分组,每组各60例,观察组采取鹽酸利托君进行静脉滴注,对照组采取硫酸镁进行静脉滴注,比较两组孕妇的治疗有效率、治疗显效时间、延长孕期时间、治疗后的不良反应发生率。比较两组新生儿出生12~24 h的Hb水平、HCT水平、住院时间、住院费用、出生时和出生3个月的体重、身高、头围。 结果 (1)观察组治疗总有效率高达91.67%,明显高于对照组的66.67%(P<0.05);(2)观察组治疗显效时间、延长孕期时间均优于对照组(P<0.05);(3)观察组肌无力、恶心、呼吸抑制的发生率明显低于对照组,观察组心悸、胸闷的发生率明显高于对照组(P<0.05);(4)与对照组相比,观察组出生12~24 h的Hb水平为(205.51±25.35)g/L和HCT水平为(68.05±3.66)%明显更高,住院时间明显比对照组更短,住院费用明显更少(P<0.05);(5)与出生时相比,观察组新生儿出生3个月的体重、身高、头围明显增长(P<0.05);与对照组相比,观察组新生儿出生3个月的体重、身高、头围明显增长(P<0.05);对照组新生儿出生时和出生3个月的体重、身高、头围明显增长,但增长幅度低于观察组(P<0.05)。 结论 采用盐酸利托君治疗先兆早产效果更加安全确切,可临床推广使用。

    [关键词] 盐酸利托君;硫酸镁;先兆早产;Hb

    [中图分类号] R714.2 [文献标识码] B [文章编号] 1673-9701(2020)28-0091-04

    Effect comparison between ritodrine hydrochloride and magnesium sulfate in patients with threatened premature delivery

    LEI Lei

    Department of Obstetrics,Chongqing Kaizhou District People's Hospital, Chongqing 405400, China

    [Abstract] Objective To investigate the effect of ritodrine hydrochloride and magnesium sulfate on patients with threatened premature delivery. Methods A total of 120 pregnant women with threatened abortion admitted to the obstetrics department of our hospital from January to December 2018 were selected as study subjects. The patients were grouped according to random number table method, with 60 cases in each group. In the observation group,ritodrine hydrochloride was administered intravenously. In the control group,magnesium sulfate was administered intravenously. The effective rate of treatment,the time of effective treatment, the prolonged duration of pregnancy and the adverse reaction rate after treatment were compared between the two groups. The Hb level, HCT level, weight, length of stay, hospitalization costs, height and head circumference at birth and 3 months after birth were compared between the two groups. Results (1)The total effective rate of treatment in the observation group was as high as 91.67%, which was significantly higher than 66.67% in the control group(P<0.05). (2)The observation group was better than the control group in terms of the time of effective treatment,and the prolonged duration of pregnancy(P<0.05). (3)The incidence of muscle weakness, nausea and respiratory depression in the observation group was significantly lower than that in the control group, and the incidence of palpitation and chest tightness in the observation group was significantly higher than that in the control group(P<0.05). (4)Compared with the control group,the observation group had significantly higher Hb level was(205.51±25.35)g/L and HCT level was(68.05±3.66)% 12-24 h after birth, shorter hospital stay and lower hospitalization costs(P<0.05). (5)Compared with those at birth, the weight, height and head circumference of newborns in the observation group increased more significantly at 3 months after birth(P<0.05). Compared with those of the control group, the weight, height and head circumference of newborns in the observation group increased more significantly at 3 months after birth(P<0.05). The weight, height and head circumference of newborns in the control group increased more significantly at birth and 3 months after birth,but the increase was lower than that in the observation group(P<0.05). Conclusion Ritodrine hydrochloride in the treatment of threatened abortion is safer and more accurate, which can be can be used for clinical popularization., http://www.100md.com(雷蕾)
1 2 3下一页